Imaging biomarkers in ovarian cancer: The role of 18F-FDG PET/CT

Paola Mapelli, Elena Incerti, Federico Fallanca, Luigi Gianolli, Maria Picchio

Research output: Contribution to journalReview articlepeer-review

Abstract

Ovarian cancer represents one of the major form of cancer in women in the western world and its silent nature leads to a late clinical manifestation at advanced stage in many patients. Therefore the role of imaging techniques is very important for the correct management of these patients. In the present review, the role of 18F-FDG-PET/CT in the different clinical settings is presented and a comparison with other imaging modalities and serum biomarker CA-125 are discussed.

Original languageEnglish
Pages (from-to)93-102
Number of pages10
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume60
Issue number2
Publication statusPublished - Jun 1 2016

Keywords

  • Biomarkers
  • Fluorodeoxyglucose F18
  • Ovarian neoplasms
  • Positron-emission tomography
  • Tomography, X-ray computed

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Imaging biomarkers in ovarian cancer: The role of <sup>18</sup>F-FDG PET/CT'. Together they form a unique fingerprint.

Cite this